BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 17001304)

  • 21. The N-terminal transmembrane domain (TMD0) and a cytosolic linker (L0) of sulphonylurea receptor define the unique intrinsic gating of KATP channels.
    Fang K; Csanády L; Chan KW
    J Physiol; 2006 Oct; 576(Pt 2):379-89. PubMed ID: 16887879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel.
    Yamada M; Isomoto S; Matsumoto S; Kondo C; Shindo T; Horio Y; Kurachi Y
    J Physiol; 1997 Mar; 499 ( Pt 3)(Pt 3):715-20. PubMed ID: 9130167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATP-sensitive K(+) channels composed of Kir6.1 and SUR2B subunits in guinea pig gastric myocytes.
    Sim JH; Yang DK; Kim YC; Park SJ; Kang TM; So I; Kim KW
    Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G137-44. PubMed ID: 11751167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of ATP-sensitive K(+) channel subunits expressed in mouse portal vein.
    Yamamoto T; Takahara K; Inai T; Node K; Teramoto N
    Vascul Pharmacol; 2015 Dec; 75():29-39. PubMed ID: 26163942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells.
    Babenko AP; Gonzalez G; Aguilar-Bryan L; Bryan J
    Circ Res; 1998 Nov; 83(11):1132-43. PubMed ID: 9831708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms of the inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on sarcolemmal adenosine triphosphate-sensitive potassium channels in the cardiovascular system.
    Kawano T; Oshita S; Takahashi A; Tsutsumi Y; Tomiyama Y; Kitahata H; Kuroda Y; Nakaya Y
    Anesthesiology; 2004 Aug; 101(2):390-8. PubMed ID: 15277922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. K ATP channels of primary human coronary artery endothelial cells consist of a heteromultimeric complex of Kir6.1, Kir6.2, and SUR2B subunits.
    Yoshida H; Feig JE; Morrissey A; Ghiu IA; Artman M; Coetzee WA
    J Mol Cell Cardiol; 2004 Oct; 37(4):857-69. PubMed ID: 15380676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.
    Rainbow RD; James M; Hudman D; Al Johi M; Singh H; Watson PJ; Ashmole I; Davies NW; Lodwick D; Norman RI
    Biochem J; 2004 Apr; 379(Pt 1):173-81. PubMed ID: 14672537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
    Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
    Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in the mechanism of metabolic regulation of ATP-sensitive K+ channels containing Kir6.1 and Kir6.2 subunits.
    Farzaneh T; Tinker A
    Cardiovasc Res; 2008 Sep; 79(4):621-31. PubMed ID: 18522960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
    Dörschner H; Brekardin E; Uhde I; Schwanstecher C; Schwanstecher M
    Mol Pharmacol; 1999 Jun; 55(6):1060-6. PubMed ID: 10347249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice.
    Suzuki M; Li RA; Miki T; Uemura H; Sakamoto N; Ohmoto-Sekine Y; Tamagawa M; Ogura T; Seino S; Marbán E; Nakaya H
    Circ Res; 2001 Mar; 88(6):570-7. PubMed ID: 11282890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. K(ATP) channel action in vascular tone regulation: from genetics to diseases.
    Shi WW; Yang Y; Shi Y; Jiang C
    Sheng Li Xue Bao; 2012 Feb; 64(1):1-13. PubMed ID: 22348955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.
    Stephan D; Stauss E; Lange U; Felsch H; Löffler-Walz C; Hambrock A; Russ U; Quast U
    Br J Pharmacol; 2005 Apr; 144(8):1078-88. PubMed ID: 15711591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisense oligodeoxynucleotides of sulfonylurea receptors inhibit ATP-sensitive K+ channels in cultured neonatal rat ventricular cells.
    Yokoshiki H; Sunagawa M; Seki T; Sperelakis N
    Pflugers Arch; 1999 Feb; 437(3):400-8. PubMed ID: 9914396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of Guanxinkang on expressions of ATP-sensitive potassium channel subunits Kir6.1, Kir6.2, SUR2A and SUR2B in ischemic myocytes of rats].
    Chen FR; Zhang N; Liu P; Zhang YY; Han XH; Cai JF
    Zhong Xi Yi Jie He Xue Bao; 2010 May; 8(5):458-64. PubMed ID: 20456845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of in vivo preconditioning by isoflurane on adenosine triphosphate-sensitive potassium channels in the rat heart: lasting modulation of nucleotide sensitivity during early memory period.
    Stadnicka A; Marinovic J; Bienengraeber M; Bosnjak ZJ
    Anesthesiology; 2006 Mar; 104(3):503-10. PubMed ID: 16508398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Voltage dependence of ATP-dependent K+ current in rat cardiac myocytes is affected by IK1 and IK(ACh).
    Wellner-Kienitz MC; Bender K; Rinne A; Pott L
    J Physiol; 2004 Dec; 561(Pt 2):459-69. PubMed ID: 15459245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.
    Hambrock A; Löffler-Walz C; Russ U; Lange U; Quast U
    Mol Pharmacol; 2001 Jul; 60(1):190-9. PubMed ID: 11408614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MCC-134, a novel vascular relaxing agent, is an inverse agonist for the pancreatic-type ATP-sensitive K(+) channel.
    Shindo T; Katayama Y; Horio Y; Kurachi Y
    J Pharmacol Exp Ther; 2000 Jan; 292(1):131-5. PubMed ID: 10604939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.